Literature DB >> 14976385

Lateral diffusion of ibuprofen in human skin during permeation studies.

G Schicksnus1, C C Müller-Goymann.   

Abstract

In order to characterize the quality of dermal preparations, permeation studies using human stratum corneum or artificial skin constructs are carried out. For a better understanding of the diffusion processes a method to measure the lateral diffusion in skin samples was developed allowing an estimation of built-up drug depots. By extracting concentric skin segments surrounding the site of application, lateral drug diffusion was determined. Both, excised human skin and artificial skin constructs, showed comparable results with two phases of lateral diffusion (accumulation/redistribution). The use of permeation enhancers promoted lateral diffusion and thus increased the tendency to create a drug depot within the skin. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14976385     DOI: 10.1159/000076018

Source DB:  PubMed          Journal:  Skin Pharmacol Physiol        ISSN: 1660-5527            Impact factor:   3.479


  4 in total

1.  Assessment of the lateral diffusion and penetration of topically applied drugs in humans using a novel concentric tape stripping design.

Authors:  C M Gee; J A Nicolazzo; A C Watkinson; B C Finnin
Journal:  Pharm Res       Date:  2012-03-16       Impact factor: 4.200

2.  Large Size Microneedle Patch to Deliver Lidocaine through Skin.

Authors:  Himanshu Kathuria; Hairui Li; Jing Pan; Seng Han Lim; Jaspreet Singh Kochhar; Chunyong Wu; Lifeng Kang
Journal:  Pharm Res       Date:  2016-07-11       Impact factor: 4.200

3.  Infrared spectroscopic imaging tracks lateral distribution in human stratum corneum.

Authors:  Qihong Zhang; Peter Saad; Guangru Mao; Russel M Walters; Mary Catherine Mack Correa; Richard Mendelsohn; Carol R Flach
Journal:  Pharm Res       Date:  2014-05-03       Impact factor: 4.200

4.  Lateral drug diffusion in human nails.

Authors:  Biji B Palliyil; Cong Li; Suzan Owaisat; David B Lebo
Journal:  AAPS PharmSciTech       Date:  2014-06-27       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.